Haloperidol decanoate
CAS No. 74050-97-8
Haloperidol decanoate ( Haldol; Neoperidole; KD 136; KD 16; KD-136 )
Catalog No. M24747 CAS No. 74050-97-8
Haloperidol decanoate is a typical antipsychotic agent utilized as maintenance treatment for schizophrenia and mood disorders formulated as an ester for intramuscular injection.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 65 | In Stock |
|
10MG | 110 | In Stock |
|
25MG | 222 | In Stock |
|
50MG | 331 | In Stock |
|
100MG | 489 | In Stock |
|
500MG | 1044 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHaloperidol decanoate
-
NoteResearch use only, not for human use.
-
Brief DescriptionHaloperidol decanoate is a typical antipsychotic agent utilized as maintenance treatment for schizophrenia and mood disorders formulated as an ester for intramuscular injection.
-
DescriptionHaloperidol decanoate is a typical antipsychotic agent utilized as maintenance treatment for schizophrenia and mood disorders formulated as an ester for intramuscular injection.
-
SynonymsHaldol; Neoperidole; KD 136; KD 16; KD-136
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number74050-97-8
-
Formula Weight530.1
-
Molecular FormulaC31H41ClFNO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCCCCCCCCC(OC1(CCN(CCCC(c(cc2)ccc2F)=O)CC1)c(cc1)ccc1Cl)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Jann MW, Penzak SR. Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents. CNS Drugs. 2018 Mar;32(3):241-257. doi: 10.1007/s40263-018-0508-6. Review. Erratum in: CNS Drugs. 2018 Jun 2;:. PubMed PMID: 29569082.
molnova catalog
related products
-
Cinnamyl acetate
——
-
HBED
HBED is an iron chelator and can be used in research on the treatment of chronic iron overload and acute iron poisoning.
-
Z-VRPR-FMK (TFA)
Z-VRPR-FMK (TFA) (VRPR) is a tetrapeptide and a selective and irreversible inhibitor of lymphoma translocation protein 1 (MALT1) in mucosa-associated lymphoid tissue.